89 Zr-Trastuzumab PET/CT Imaging of HER2-Positive Breast Cancer for Predicting Pathological Complete Response after Neoadjuvant Systemic Therapy: A Feasibility Study.
Daan G J LindersM M DekenMartijn A van DamMartin N J M WasserE M C VoormolenJudith R KroepG A M S van DongenD VugtsH M OosterkampM E StraverC J H van de VeldeD CohenPetra Dibbets-SchneiderFloris H P van VeldenL M Pereira Arias-BoudaA L VahrmeijerG J LiefersLioe-Fee De Geus-OeiDenise E HillingPublished in: Cancers (2023)
Zr-trastuzumab PET/CT has potential for a more accurate response evaluation of the primary tumor after NAT in HER2-positive breast cancer.
Keyphrases
- pet ct
- positive breast cancer
- epidermal growth factor receptor
- pet imaging
- high resolution
- metastatic breast cancer
- positron emission tomography
- rectal cancer
- lymph node
- locally advanced
- tyrosine kinase
- stem cells
- squamous cell carcinoma
- radiation therapy
- computed tomography
- photodynamic therapy
- replacement therapy